from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2884/-

LFCtreatmentdescriptionclass of inhibitor

-0.654

Amikacinug/mL Amikacintranslation

-0.763

Cap5-10ug/mL Capreomycintranslation

-0.520

Rox10-50 ug/mL Roxithromycintranslation

0.348

SM2-5 ug/mL Streptomycintranslation

-1.830

Tet5-10 ug/mL Tetracyclinetranslation

-0.020

Rif0.2-5ug/mL Rifampicintranscription

0.010

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.801

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.291

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.298

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.514

Clofazimine10-13 ug/mL Clofaziminerespiration

0.176

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-3.719

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.313

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.755

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.453

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.062

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.441

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.810

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.880

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.896

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.929

Nigericin50 uM Nigericinrespiration

0.880

TRC10-150 ug/mL Triclosanrespiration

-1.400

TRZ10-25 ug/mL Thioridazinerespiration

-0.002

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

1.307

menadione6-10 ug/mL Menadionerespiration

0.038

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.121

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.112

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.590

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.921

NRP_1Non-replicating persistence stage 1dosRassociated

0.209

Amp0.2mg/mL AmpicillincellWall

-0.441

Cephalexin20-100 ug/mL CephalexincellWall

0.161

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.247

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.158

EMB10-20 ug/mL EthambutolcellWall

0.195

Eta12-40 ug/mL EthionamidecellWall

0.252

INH0.2-0.4 ug/mL IsoniazidcellWall

0.208

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.013

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.001

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.581

BZA0.12 mg/mL BenzamidearomaticAmides

0.513

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.208

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.210

H2O24 mM hydrogen peroxideDNAdamaging

0.057

Levo10 ug/mL LevofloxacinDNAdamaging

0.390

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.109

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.230

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.443

UVUV-irradiationDNAdamaging

1.388

ARP41-4 ug/mL Antitubercular compound ARP4?

0.095

Antimycin12.5-50 ug/mL Antimycin A?

-0.342

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.087

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.603

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.265

PA8240.2-2 ug/mL PA-824?

-0.058

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.023

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.025

Verapamil50 uM Verapamil?

0.223

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.645

methoxatin10-20 ug/mL Methoxatin?